STARCLOSE VASCULAR CLOSURE SYSTEM

Device, Hemostasis, Vascular

FDA Premarket Approval P050007

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the starclose vascular closure system. The device is indicated for the percutaneous closure of common femoral artery access sites while reducing times to hemostasis, ambulation, and dischargeability in patients who have undergone diagnostic endovascular catheterization procedures utilizing a 5f or 6f procedural sheath.

DeviceSTARCLOSE VASCULAR CLOSURE SYSTEM
Classification NameDevice, Hemostasis, Vascular
Generic NameDevice, Hemostasis, Vascular
ApplicantABBOTT VASCULAR DEVICES
Date Received2005-02-28
Decision Date2005-12-21
Notice Date2006-01-13
PMAP050007
SupplementS
Product CodeMGB
Docket Number06M-0016
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address ABBOTT VASCULAR DEVICES 3200 Lakeside Drive santa Clara, CA 95054
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P050007Original Filing
S043 2022-11-21 135 Review Track For 30-day Notice
S042 2022-11-16 30-day Notice
S041 2021-05-18 30-day Notice
S040 2020-11-05 30-day Notice
S039 2020-03-06 30-day Notice
S038 2019-04-24 30-day Notice
S037 2018-11-13 Normal 180 Day Track No User Fee
S036 2018-04-02 30-day Notice
S035 2018-03-23 30-day Notice
S034 2016-11-21 30-day Notice
S033 2015-02-25 Normal 180 Day Track No User Fee
S032 2014-09-12 30-day Notice
S031 2013-07-18 135 Review Track For 30-day Notice
S030 2012-06-12 30-day Notice
S029 2011-07-18 30-day Notice
S028 2011-02-22 Special (immediate Track)
S027 2010-10-05 Real-time Process
S026 2010-05-06 30-day Notice
S025 2010-04-23 30-day Notice
S024 2010-02-23 Real-time Process
S023 2009-11-02 Real-time Process
S022 2009-09-11 30-day Notice
S021 2009-09-10 30-day Notice
S020 2009-08-20 30-day Notice
S019 2009-08-04 30-day Notice
S018 2009-08-04 30-day Notice
S017 2009-07-22 30-day Notice
S016 2009-07-06 30-day Notice
S015 2009-06-30 135 Review Track For 30-day Notice
S014 2009-05-28 Normal 180 Day Track No User Fee
S013 2009-03-02 Real-time Process
S012 2008-08-22 30-day Notice
S011 2008-08-15 30-day Notice
S010 2008-07-02 Special (immediate Track)
S009 2008-03-31 Normal 180 Day Track
S008 2007-12-20 30-day Notice
S007 2007-12-12 30-day Notice
S006 2007-05-07 Real-time Process
S005 2007-02-21 30-day Notice
S004 2006-10-24 Real-time Process
S003 2006-07-05 Real-time Process
S002 2006-02-09 Special (immediate Track)
S001 2005-12-27 Panel Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.